Quality indicators for endometrial cancer care in Japan
Journal of Gynecologic Oncology · 2025
DOI: 10.3802/jgo.2025.36.e77 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2025. Verfasst von Tamaki Kakuwa und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Health Services Research, Institute for Cancer Control, National Cancer Center, Tokyo, Japan. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Quality Indicators, Health Care, Guideline Adherence. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
OBJECTIVE: The incidence and mortality rates of endometrial cancer are increasing globally, including in Japan. Quality of cancer care is promoted through guideline adherence. This study aimed to establish quality indicators (QIs) for endometrial cancer and explore the factors contributing to treatment nonadherence. METHODS: QIs and pattern-of-care indicators (PCIs) were developed using the Research and Development/University of California Los Angeles modified Delphi method. QIs reflect desirable healthcare patterns, whereas PCIs address treatment areas with lacking evidence. Data from the Hospital-Based Cancer Registry and Diagnosis Procedure Combination Survey were used. Patients diagnosed or treated between January 1 and December 31, 2020 were included. The reasons for nonadherence were collected. Logistic regression was used to analyze the factors influencing adherence, including age, body mass index, comorbidities, facilities, and recurrence risk. RESULTS: Of the 35 proposed QI candidates, 8 QIs and 9 PCIs were selected, predominantly focusing on surgical aspects. Adherence rates varied, with peritoneal lavage cytology being the highest (93.1%), and postoperative hormone replacement therapy (HRT) for patients aged
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Health Services Research, Institute for Cancer Control, National Cancer Center, Tokyo, Japan.
- Department of Public Health and Health Policy, Graduate School of Medicine, University of Tokyo, Tokyo, Japan. tamaki.kakuwa@gmail.com.
- Department of Public Health and Health Policy, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
- Department of Obstetrics and Gynecology, Yamagata University School of Medicine, Yamagata, Japan.
- Department of Obstetrics and Gynecology, Kyorin University Faculty of Medicine, Tokyo, Japan.
- Department of Gynecology, Otaru General Hospital, Otaru, Japan.
ORCID-Profile: Tamaki Kakuwa, Yuichi Ichinose, Ryoko Rikitake, Satoru Nagase, Yoichi Kobayashi, Masanori Kaneuchi, Hideki Tokunaga, Manabu Seino, Munetaka Takekuma, Tsutomu Tabata, Yoshito Terai, Yasuhisa Terao, Tohru Morisada, Hidemichi Watari, Yoko Yamamoto, Akira Kawata, Takahiro Higashi
Zitieren
APA
Kakuwa, T., Ichinose, Y., Rikitake, R., Ishii, T., Nagase, S., Kobayashi, Y., Kaneuchi, M., Tokunaga, H., Seino, M., Kajiyama, H., Takekuma, M., Tabata, T., Terai, Y., Terao, Y., Morisada, T., Watari, H., Yamamoto, Y., Kawata, A., & Higashi, T. (2025). Quality indicators for endometrial cancer care in Japan. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2025.36.e77
Vancouver
Kakuwa T, Ichinose Y, Rikitake R, Ishii T, Nagase S, Kobayashi Y, et al. Quality indicators for endometrial cancer care in Japan. Journal of Gynecologic Oncology. 2025. doi:10.3802/jgo.2025.36.e77
BibTeX
@article{Kakuwa2025,
author = {Kakuwa, Tamaki and Ichinose, Yuichi and Rikitake, Ryoko and Ishii, Taisuke and Nagase, Satoru and Kobayashi, Yoichi and Kaneuchi, Masanori and Tokunaga, Hideki and Seino, Manabu and Kajiyama, Hiroaki and Takekuma, Munetaka and Tabata, Tsutomu and Terai, Yoshito and Terao, Yasuhisa and Morisada, Tohru and Watari, Hidemichi and Yamamoto, Yoko and Kawata, Akira and Higashi, Takahiro},
title = {Quality indicators for endometrial cancer care in Japan},
journal = {Journal of Gynecologic Oncology},
year = {2025},
doi = {10.3802/jgo.2025.36.e77}
}
EUVIMED